These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 27667787)

  • 1. Tolerogenic dendritic cells generated with dexamethasone and vitamin D3 regulate rheumatoid arthritis CD4
    Anderson AE; Swan DJ; Wong OY; Buck M; Eltherington O; Harry RA; Patterson AM; Pratt AG; Reynolds G; Doran JP; Kirby JA; Isaacs JD; Hilkens CM
    Clin Exp Immunol; 2017 Jan; 187(1):113-123. PubMed ID: 27667787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of porcine-specific regulatory T cells with high specificity and expression of IL-10 and TGF-β1 using baboon-derived tolerogenic dendritic cells.
    Li M; Eckl J; Abicht JM; Mayr T; Reichart B; Schendel DJ; Pohla H
    Xenotransplantation; 2018 Jan; 25(1):. PubMed ID: 29057512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting of tolerogenic dendritic cells to heat-shock proteins in inflammatory arthritis.
    Spiering R; Jansen MAA; Wood MJ; Fath AA; Eltherington O; Anderson AE; Pratt AG; van Eden W; Isaacs JD; Broere F; Hilkens CMU
    J Transl Med; 2019 Nov; 17(1):375. PubMed ID: 31727095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation and characterisation of therapeutic tolerogenic dendritic cells for rheumatoid arthritis.
    Harry RA; Anderson AE; Isaacs JD; Hilkens CM
    Ann Rheum Dis; 2010 Nov; 69(11):2042-50. PubMed ID: 20551157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tolerogenic dendritic cell therapy for rheumatoid arthritis: where are we now?
    Hilkens CM; Isaacs JD
    Clin Exp Immunol; 2013 May; 172(2):148-57. PubMed ID: 23574312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A mouse model of adoptive immunotherapeutic targeting of autoimmune arthritis using allo-tolerogenic dendritic cells.
    Yang J; Yang Y; Ren Y; Xie R; Zou H; Fan H
    PLoS One; 2013; 8(10):e77729. PubMed ID: 24204938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Matured Tolerogenic Dendritic Cells Effectively Inhibit Autoantigen Specific CD4
    Jansen MAA; Spiering R; Ludwig IS; van Eden W; Hilkens CMU; Broere F
    Front Immunol; 2019; 10():2068. PubMed ID: 31555285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Developing tolerogenic dendritic cell therapy for rheumatoid arthritis: what can we learn from mouse models?
    Stoop JN; Robinson JH; Hilkens CM
    Ann Rheum Dis; 2011 Sep; 70(9):1526-33. PubMed ID: 21804099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LPS activation is required for migratory activity and antigen presentation by tolerogenic dendritic cells.
    Anderson AE; Swan DJ; Sayers BL; Harry RA; Patterson AM; von Delwig A; Robinson JH; Isaacs JD; Hilkens CM
    J Leukoc Biol; 2009 Feb; 85(2):243-50. PubMed ID: 18971286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neutrophil elastase treated dendritic cells promote the generation of CD4(+)FOXP3(+) regulatory T cells in vitro.
    Tateosian NL; Reiteri RM; Amiano NO; Costa MJ; Villalonga X; Guerrieri D; Maffía PC
    Cell Immunol; 2011; 269(2):128-34. PubMed ID: 21477798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human leukocyte antigen-G expression on dendritic cells induced by transforming growth factor-beta1 and CD4+ T cells proliferation.
    Abediankenari S; Ghasemi M; Kim YJ
    Iran Biomed J; 2011; 15(1-2):1-5. PubMed ID: 21725493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro suppression of immune responses using monocyte-derived tolerogenic dendritic cells from patients with primary Sjögren's syndrome.
    Volchenkov R; Brun JG; Jonsson R; Appel S
    Arthritis Res Ther; 2013; 15(5):R114. PubMed ID: 24025795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A unique subset of CD4+CD25highFoxp3+ T cells secreting interleukin-10 and transforming growth factor-beta1 mediates suppression in the tumor microenvironment.
    Strauss L; Bergmann C; Szczepanski M; Gooding W; Johnson JT; Whiteside TL
    Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4345-54. PubMed ID: 17671115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tolerogenic dendritic cells modified by tacrolimus suppress CD4(+) T-cell proliferation and inhibit collagen-induced arthritis in mice.
    Ren Y; Yang Y; Yang J; Xie R; Fan H
    Int Immunopharmacol; 2014 Jul; 21(1):247-54. PubMed ID: 24836681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early exposure of interferon-γ inhibits signal transducer and activator of transcription-6 signalling and nuclear factor κB activation in a short-term monocyte-derived dendritic cell culture promoting 'FAST' regulatory dendritic cells.
    Rojas-Canales D; Krishnan R; Jessup CF; Coates PT
    Clin Exp Immunol; 2012 Mar; 167(3):447-58. PubMed ID: 22288588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancement of Anti-Leukemia Immunity by Leukemia-Derived Exosomes Via Downregulation of TGF-β1 Expression.
    Huang F; Wan J; Hu W; Hao S
    Cell Physiol Biochem; 2017; 44(1):240-254. PubMed ID: 29130994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative transcriptomic profile of tolerogenic dendritic cells differentiated with vitamin D3, dexamethasone and rapamycin.
    Navarro-Barriuso J; Mansilla MJ; Naranjo-Gómez M; Sánchez-Pla A; Quirant-Sánchez B; Teniente-Serra A; Ramo-Tello C; Martínez-Cáceres EM
    Sci Rep; 2018 Oct; 8(1):14985. PubMed ID: 30297862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dendritic cells with TGF-β1 and IL-2 differentiate naive CD4+ T cells into alloantigen-specific and allograft protective Foxp3+ regulatory T cells.
    Yang H; Cheng EY; Sharma VK; Lagman M; Chang C; Song P; Ding R; Muthukumar T; Suthanthiran M
    Transplantation; 2012 Mar; 93(6):580-8. PubMed ID: 22270834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human tolerogenic dendritic cells generated with protein kinase C inhibitor are optimal for functional regulatory T cell induction - A comparative study.
    Adnan E; Matsumoto T; Ishizaki J; Onishi S; Suemori K; Yasukawa M; Hasegawa H
    Clin Immunol; 2016 Dec; 173():96-108. PubMed ID: 27658741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative study of clinical grade human tolerogenic dendritic cells.
    Naranjo-Gómez M; Raïch-Regué D; Oñate C; Grau-López L; Ramo-Tello C; Pujol-Borrell R; Martínez-Cáceres E; Borràs FE
    J Transl Med; 2011 Jun; 9():89. PubMed ID: 21658226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.